48 related articles for article (PubMed ID: 38647238)
21. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Belda MALF; Averous G; Leroux A; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
Gynecol Oncol; 2022 Nov; 167(2):373-389. PubMed ID: 36114030
[TBL] [Abstract][Full Text] [Related]
22. Endometrial stromal tumors: an update on a group of tumors with a protean phenotype.
Oliva E; Clement PB; Young RH
Adv Anat Pathol; 2000 Sep; 7(5):257-81. PubMed ID: 10976906
[TBL] [Abstract][Full Text] [Related]
23. Update on Uterine Mesenchymal Neoplasms.
Kertowidjojo EC; Bennett JA
Surg Pathol Clin; 2022 Jun; 15(2):315-340. PubMed ID: 35715164
[TBL] [Abstract][Full Text] [Related]
24. Endometrial stromal tumors: A clinico-histomorphological spectrum of endometrial stromal tumors with review of literature.
Verma A; Tomar R; Chaturvedi A; Dhankar N; Mallya V; Khurana N
J Cancer Res Ther; 2024 Jan; 20(1):150-155. PubMed ID: 38554313
[TBL] [Abstract][Full Text] [Related]
25. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
[TBL] [Abstract][Full Text] [Related]
26. The value of immunohistochemical methods in diagnosing mesenchymal tumours of the uterus.
Dundr P; Gregová M; Němejcová K; Bártů M; Bennett RJ; Stružinská I
Cesk Patol; 2021; 57(2):86-95. PubMed ID: 34275318
[TBL] [Abstract][Full Text] [Related]
27. Smooth Muscle Tumors of the Female Genital Tract.
Mills AM; Longacre TA
Surg Pathol Clin; 2009 Dec; 2(4):625-77. PubMed ID: 26838774
[TBL] [Abstract][Full Text] [Related]
28. The pathology of uterine smooth muscle tumors and mixed endometrial stromal-smooth muscle tumors: a selective review with emphasis on recent advances.
Clement PB
Int J Gynecol Pathol; 2000 Jan; 19(1):39-55. PubMed ID: 10638452
[TBL] [Abstract][Full Text] [Related]
29. [Endometrial and other rare uterine sarcomas : Diagnostic aspects in the context of the 2020 WHO classification].
Mayr D; Horn LC; Hiller GGR; Höhn AK; Schmoeckel E
Pathologe; 2022 May; 43(3):183-195. PubMed ID: 35362728
[TBL] [Abstract][Full Text] [Related]
30. Smooth muscle tumors of the uterus: a practical approach.
Toledo G; Oliva E
Arch Pathol Lab Med; 2008 Apr; 132(4):595-605. PubMed ID: 18384211
[TBL] [Abstract][Full Text] [Related]
31. Mass lesions of the myometrium: interpretation and management of unexpected pathology.
Porter AE; Kho KA; Gwin K
Curr Opin Obstet Gynecol; 2019 Oct; 31(5):349-355. PubMed ID: 31425175
[TBL] [Abstract][Full Text] [Related]
32. ZC3H7B-BCOR Fusion High-grade Endometrial Stromal Sarcoma With Morphologic Features of Low-grade Endometrial Stromal Sarcoma. A Case Report and Review of Literature.
Zhao L; Cheng YW; Policarpio-Nicolas MLC
Int J Gynecol Pathol; 2023 Nov; 42(6):597-601. PubMed ID: 37562066
[TBL] [Abstract][Full Text] [Related]
33. Pathology of uterine leiomyosarcomas and smooth muscle tumours of uncertain malignant potential.
Ip PP; Cheung AN
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):691-704. PubMed ID: 21865091
[TBL] [Abstract][Full Text] [Related]
34. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy.
Ip PP; Tse KY; Tam KF
Adv Anat Pathol; 2010 Mar; 17(2):91-112. PubMed ID: 20179432
[TBL] [Abstract][Full Text] [Related]
35. Myxoid Leiomyosarcoma of the Uterus: A Clinicopathologic Analysis of 30 Cases and Review of the Literature With Reappraisal of Its Distinction From Other Uterine Myxoid Mesenchymal Neoplasms.
Parra-Herran C; Schoolmeester JK; Yuan L; Dal Cin P; Fletcher CD; Quade BJ; Nucci MR
Am J Surg Pathol; 2016 Mar; 40(3):285-301. PubMed ID: 26866354
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in smooth muscle tumors with PGR and PLAG1 gene fusions and myofibroblastic uterine neoplasms.
Chiang S
Genes Chromosomes Cancer; 2021 Mar; 60(3):138-146. PubMed ID: 33230916
[TBL] [Abstract][Full Text] [Related]
37. Atypical uterine leiomyoma: a case report and review of the literature.
Manxhuka-Kerliu S; Kerliu-Saliu I; Sahatciu-Meka V; Kerliu L; Shahini L
J Med Case Rep; 2016 Jan; 10():22. PubMed ID: 26801982
[TBL] [Abstract][Full Text] [Related]
38. Sarcomas and related proliferative lesions of specialized prostatic stroma: a clinicopathologic study of 22 cases.
Gaudin PB; Rosai J; Epstein JI
Am J Surg Pathol; 1998 Feb; 22(2):148-62. PubMed ID: 9500215
[TBL] [Abstract][Full Text] [Related]
39. Pathology of uterine malignancies.
Brown L
Clin Oncol (R Coll Radiol); 2008 Aug; 20(6):433-47. PubMed ID: 18499412
[TBL] [Abstract][Full Text] [Related]
40. Malignant mesenchymal tumors of the uterus - time to advocate a genetic classification.
Rommel B; Holzmann C; Bullerdiek J
Expert Rev Anticancer Ther; 2016 Nov; 16(11):1155-1166. PubMed ID: 27602604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
